ftInvstr
ASTRAZEN · Healthcare ₹6950.0 +0.04% Mkt Cap ₹17255 Cr

ASTRAZEN

Healthcare Drug Manufacturers - Specialty & Generic
₹6950.0
+0.04% today · 30d -13.83%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for ASTRAZEN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹683 Cr
+29.73% YoY
NET PROFIT
₹38 Cr
-32.06% YoY
OPM
8.41%
-8.77pp YoY
EPS
₹15.17
PE 100.68
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.1% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
ASTRAZEN100.68
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
42
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth STRONG 81
Profitability DECENT 55
Technicals BEARISH 18
Risk LOW 70
Key Stats
TTM PE
100.68
P/B
19.62
52W HIGH
₹9849.5
OFF HIGH
-29.44%
DIV YIELD
0.52%
MKT CAP
₹17255 Cr
◉ Active Signals
MACDBearish-27.8659
RSI(14)Bullish25.02
Near 52W LowBearish1.68
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ASTRAZEN and at what entry.

Sign up freeSign in